跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MED-DORZOLAMIDE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MED-DORZOLAMIDE
Authorized
STANDARD
MED-DORZOLAMIDE
generic medical partners inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
4d04fd4953781a6c
Company
generic medical partners inc
Type
Standard
Approval Details
Approval Id
4d04fd4953781a6c
Drug Approval Canada Name
MED-DORZOLAMIDE
Product Name
MED-DORZOLAMIDE
Status
Marketed
Status Date
2023-05-26
Original Market Date
2023-05-26
Din
02457210
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Ophthalmic
Schedule
Prescription
Ahfs
52:40.12
Atc Original
S01EC03 DORZOLAMIDE
Atc Name
s 01 ec 03
Aig Number
0128558001
Company Name
generic medical partners inc
Company Address
1500 Don Mills Road, Suite 711, Toronto, Ontario, Canada, M3B 3K4
Active Ingredients
DORZOLAMIDE (DORZOLAMIDE HYDROCHLORIDE)
2 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
4d04fd4953781a6c
Type
Standard
Back to Health Canada Approvals